Abstract
Programming T cells to distinguish self from non-self is a vital, multi-step process that occurs in the thymus1,2,3,4. Signalling through the pre-T cell receptor (preTCR), a CD3-associated heterodimer comprising an invariant pTα chain and a clone-specific β chain, is a critical early checkpoint in thymocyte development within the αβ T cell lineage5,6. PreTCRs arrayed on CD4−CD8− double-negative thymocytes ligate peptides bound to major histocompatibility complex molecules (pMHC) on thymic stroma, similar to αβ T cell receptors that appear on CD4+CD8+ double-positive thymocytes, but via a different molecular docking strategy7,8,9,10. Here we show the consequences of these distinct interactions for thymocyte progression using synchronized fetal thymic progenitor cultures that differ in the presence or absence of pMHC on support stroma, and single-cell transcriptomes at key thymocyte developmental transitions. Although major histocompatibility complex (MHC)-negative stroma fosters αβ T cell differentiation, the absence of preTCR–pMHC interactions leads to deviant thymocyte transcriptional programming associated with dedifferentiation. Highly proliferative double-negative and double-positive thymocyte subsets emerge, with antecedent characteristics of T cell lymphoblastic and myeloid malignancies. Compensatory upregulation of diverse MHC class Ib proteins in B2m/H2-Ab1 MHC-knockout mice partially safeguards in vivo thymocyte progression, although disseminated double-positive thymic tumours may develop with ageing. Thus, as well as promoting β chain repertoire broadening for subsequent αβ T cell receptor utilization, preTCR–pMHC interactions limit cellular plasticity to facilitate normal thymocyte differentiation and proliferation that, if absent, introduce developmental vulnerabilities.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
All sequence files have been deposited at NCBI Gene Expression Omnibus (GEO) under accession GSE186049. Source data are provided with this paper.
References
Hosokawa, H. & Rothenberg, E. V. How transcription factors drive choice of the T cell fate. Nat. Rev. Immunol. 21, 162–176 (2021).
Koch, U. et al. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205, 2515–2523 (2008).
Rodewald, H. R., Ogawa, M., Haller, C., Waskow, C. & DiSanto, J. P. Pro-thymocyte expansion by c-kit and the common cytokine receptor γ chain is essential for repertoire formation. Immunity 6, 265–272 (1997).
Shortman, K., Egerton, M., Spangrude, G. J. & Scollay, R. The generation and fate of thymocytes. Semin. Immunol. 2, 3–12 (1990).
Kreslavsky, T. et al. β-Selection-induced proliferation is required for αβ T cell differentiation. Immunity 37, 840–853 (2012).
von Boehmer, H. The thymus in immunity and in malignancy. Cancer Immunol. Res. 2, 592–597 (2014).
Das, D. K. et al. Pre-T cell receptors (Pre-TCRs) leverage Vβ complementarity determining regions (CDRs) and hydrophobic patch in mechanosensing thymic self-ligands. J. Biol. Chem. 291, 25292–25305 (2016).
Li, X. et al. Pre-T cell receptors topologically sample self-ligands during thymocyte β-selection. Science 371, 181–185 (2021).
Mallis, R. J., Arthanari, H., Lang, M. J., Reinherz, E. L. & Wagner, G. NMR-directed design of pre-TCRβ and pMHC molecules implies a distinct geometry for pre-TCR relative to αβTCR recognition of pMHC. J. Biol. Chem. 293, 754–766 (2018).
Mallis, R. J. et al. Pre-TCR ligand binding impacts thymocyte development before αβTCR expression. Proc. Natl Acad. Sci. USA 112, 8373–8378 (2015).
Davis, M. M. & Bjorkman, P. J. T-cell antigen receptor genes and T-cell recognition. Nature 334, 395–402 (1988).
Rudolph, M. G., Stanfield, R. L. & Wilson, I. A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24, 419–466 (2006).
Wang, J. H. & Reinherz, E. L. The structural basis of αβ T-lineage immune recognition: TCR docking topologies, mechanotransduction, and co-receptor function. Immunol. Rev. 250, 102–119 (2012).
Saint-Ruf, C. et al. Analysis and expression of a cloned pre-T cell receptor gene. Science 266, 1208–1212 (1994).
Xiong, J., Armato, M. A. & Yankee, T. M. Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development. Int. Immunol. 23, 55–64 (2011).
Petrie, H. T. et al. Multiple rearrangements in T cell receptor α chain genes maximize the production of useful thymocytes. J. Exp. Med. 178, 615–622 (1993).
Shinkai, Y. et al. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 259, 822–825 (1993).
Wilson, A., Held, W. & MacDonald, H. R. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179, 1355–1360 (1994).
Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat. Rev. Immunol. 14, 377–391 (2014).
Fehling, H. J., Krotkova, A., Saint-Ruf, C. & von Boehmer, H. Crucial role of the pre-T-cell receptor α gene in development of αβ but not γδ T cells. Nature 375, 795–798 (1995).
Grusby, M. J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913–3917 (1993).
Irving, B. A., Alt, F. W. & Killeen, N. Thymocyte development in the absence of pre-T cell receptor extracellular immunoglobulin domains. Science 280, 905–908 (1998).
Koller, B. H., Marrack, P., Kappler, J. W. & Smithies, O. Normal development of mice deficient in β2M, MHC class I proteins, and CD8+ T cells. Science 248, 1227–1230 (1990).
Mizsei, R. et al. A general chemical crosslinking strategy for structural analyses of weakly interacting proteins applied to preTCR–pMHC complexes. J. Biol. Chem. 296, 100255 (2021).
Xiao, S. Y., Li, Y. & Chen, W. F. Kinetics of thymocyte developmental process in fetal and neonatal mice. Cell Res. 13, 265–273 (2003).
Mingueneau, M. et al. The transcriptional landscape of αβ T cell differentiation. Nat. Immunol. 14, 619–632 (2013).
Allman, D. et al. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194, 99–106 (2001).
Forman, J. & Fischer Lindahl, K. Listing, location, binding motifs, and expression of nonclassical class i and related genes and molecules. Curr. Protoc. Immunol. 49, A.1M.1–A.1M.13 (2002).
Fujita, T., Yuno, M., Okuzaki, D., Ohki, R. & Fujii, H. Identification of non-coding RNAs associated with telomeres using a combination of enChIP and RNA sequencing. PLoS ONE 10, e0123387 (2015).
Lin, Y. W. & Aplan, P. D. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia 21, 1276–1284 (2007).
Li, R. & Guan, M. X. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol. Cell. Biol. 30, 2147–2154 (2010).
Coustan-Smith, E. et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 10, 147–156 (2009).
Vadillo, E., Dorantes-Acosta, E., Pelayo, R. & Schnoor, M. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. Blood Rev. 32, 36–51 (2018).
Dai, Y.-T. et al. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. Proc. Natl Acad. Sci. USA 119, e2120787119 (2022).
Pellicci, D. G., Koay, H. F. & Berzins, S. P. Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge. Nat. Rev. Immunol. 20, 756–770 (2020).
Thoms, J. A. I. et al. Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells. Blood 138, 1441–1455 (2021).
Ng, S. W. et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature 540, 433–437 (2016).
Mandal, M. et al. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J. Exp. Med. 201, 603–614 (2005).
Koyasu, S. et al. Pre-TCR signaling components trigger transcriptional activation of a rearranged TCR α gene locus and silencing of the pre-TCR α locus: implications for intrathymic differentiation. Int. Immunol. 9, 1475–1480 (1997).
Amson, R. et al. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl Acad. Sci. USA 86, 8857–8861 (1989).
Reinherz, E. L., Kung, P. C., Goldstein, G., Levey, R. H. & Schlossman, S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl Acad. Sci. USA 77, 1588–1592 (1980).
Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398–3406 (2012).
Girardi, T., Vicente, C., Cools, J. & De Keersmaecker, K. The genetics and molecular biology of T-ALL. Blood 129, 1113–1123 (2017).
Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012).
Condorelli, G. L. et al. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56, 5113–5119 (1996).
Kelliher, M. A., Seldin, D. C. & Leder, P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J. 15, 5160–5166 (1996).
De Keersmaecker, K. et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat. Med. 16, 1321–1327 (2010).
Rakowski, L. A., Lehotzky, E. A. & Chiang, M. Y. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma. PLoS ONE 6, e16761 (2011).
Martins, V. C. et al. Cell competition is a tumour suppressor mechanism in the thymus. Nature 509, 465–470 (2014).
Paiva, R. A. et al. Self-renewal of double-negative 3 early thymocytes enables thymus autonomy but compromises the β-selection checkpoint. Cell Rep. 35, 108967 (2021).
Khan, M., Siddiqi, R. & Naqvi, K. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Ann. Hematol. 97, 945–953 (2018).
Kai, T. & Spradling, A. Differentiating germ cells can revert into functional stem cells in Drosophila melanogaster ovaries. Nature 428, 564–569 (2004).
Cobaleda, C., Jochum, W. & Busslinger, M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449, 473–477 (2007).
Laiosa, C. V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L. & Graf, T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25, 731–744 (2006).
Riddell, J. et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157, 549–564 (2014).
Jacobs, H. et al. Oncogenic potential of a pre-T cell receptor lacking the TCRβ variable domain. Oncogene 12, 2089–2099 (1996).
Charnley, M., Ludford-Menting, M., Pham, K. & Russell, S. M. A new role for Notch in the control of polarity and asymmetric cell division of developing T cells. J. Cell Sci. 133, jcs235358 (2019).
Mohtashami, M. et al. Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J. Immunol. 185, 867–876 (2010).
Mamedov, I. Z. et al. Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling. Front. Immunol. 4, 456 (2013).
Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).
Shugay, M. et al. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput. Biol. 11, e1004503 (2015).
Wang, X., Spandidos, A., Wang, H. & Seed, B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 40, D1144–D1149 (2012).
Ruijter, J. M. et al. Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications. Methods 59, 32–46 (2013).
Shugay, M. et al. Towards error-free profiling of immune repertoires. Nat. Methods 11, 653–655 (2014).
Han, F. F. et al. Profiling the pattern of human TRB/IGH-CDR3 repertoire in liver transplantation patients via high-throughput sequencing analysis. Scand. J. Immunol. 92, e12912 (2020).
Stevant, I. et al. Dissecting cell lineage specification and sex fate determination in gonadal somatic cells using single cell transcriptomics. Cell Rep. 26, 3272–3283.e3 (2019).
Godfrey, A. K. et al. Quantitative analysis of Y-chromosome gene expression across 36 human tissues. Genome Res. 30, 860–873 (2020).
Acknowledgements
This research was supported by NIH NIAID grant AI136301. C.M.M. and P.H.L. were supported additionally by the Expect Miracles Foundation and the Robert and Renée Belfer Foundation. We thank J.-h. Wang for scientific discussion and insight, D. A. Barbie and C. P. Paweletz for facilitating the scRNA-seq analyses, the Dana-Farber/Harvard Cancer Center Specialized Histopathology Core (NIH NCI grant P30 CA006516-57) and S. Moskovitz for graphic design of figures.
Author information
Authors and Affiliations
Contributions
Conceptualization: J.S.D.-C., A.A., R.J.M., W.H., M.J.L. and E.L.R. Methodology: J.S.D.-C., A.A., R.J.M. and E.L.R. Investigation: J.S.D.-C, A.A., C.M.M., P.H.L. and J.C.A. Writing, original draft: J.S.D.-C. and E.L.R. Writing, review and editing: J.S.D.-C., R.J.M., A.A., W.H., M.J.L. and E.L.R. Funding acquisition: M.J.L., E.L.R. and J.C.A. Supervision: J.S.D.-C. and E.L.R.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature thanks Charles Mullighan, Hans-Reimer Rodewald and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Schematic for FACS isolation of thymocyte subsets (DN3a, DN3b, DN4, DP) for 10X scRNA-Seq and single cell TCR α and β chain clonotype sequencing.
Sorted cells were isolated as DN3a cells (CD25+CD44−CD28−), DN3b cells (CD25+CD44−CD28+), DN4 (CD25−CD44−CD28+) cells, and DP (CD4+CD8+) cells.
Extended Data Fig. 2 Cluster delineation of DN3a to DPsm cell transitions.
For each transition, data from the Immune Genome Project (IGP) microarray and RNA-Seq data was used to construct a panel representing genes with the highest fold-change between phenotypically defined stages of thymocyte differentiation. The gene panel was then used to query the MHC+ thymocyte clusters identified by UMAP projection. Combination of library phenotype together with good fit to the interrogating gene panel permitted identification of cluster relationships and developmental trajectories. a. Delineation of early post-β selection checkpoint DN3a/3b thymocytes from pre-β selection checkpoint DN3a thymocytes by differential gene expression. The left-hand heatmap depicts a panel selected by comparison of DN3b thymocyte gene expression from the IGP with DN3a cell expression. The same genes were examined for expression in the clusters defined as DN3a and DN3a/3b in Fig. 1B (right-hand heatmap). The volcano plot depicts the log2-fold increase of expression in the DN3a/3b population over DN3a for the expected normal developmental trajectory (x-axis). Note that for all volcano plots reported here, only the significantly changed transcripts are depicted (Padj < 0.05; y-axis). b. Delineation of late post-β selection checkpoint DN3b/4 thymocytes from early pre-β selection checkpoint DN3a/3b thymocytes by differential gene expression. The heatmap on the far left depicts a panel selected by comparison of DN4 thymocyte gene expression from the IGP with DN3b cell expression (neither DN3a/3b nor DN3b/4 transitional states are explicitly defined in the IGP database). Transcripts in red were predicted from IGP data to be upregulated in the DN3b to DN4 transition but are downregulated for the conditions reported here. c. Delineation of late post-β selection checkpoint DN3b/4 thymocytes from DPbl thymocytes by differential gene expression. The DPbl cluster was extracted from the DP library and delineated from the more mature DPsm population by transcriptome signature as described below. d. Delineation of mature DPsm thymocytes from cycling DPbl thymocytes by differential gene expression. The heatmap on the far left depicts a panel selected by comparison of DPsm thymocyte gene expression from the IGP with DPbl cell. Note that during the DPbl to DPsm transition, significant cell cycling transcripts were downregulated thus significantly upregulated transcripts in the volcano plot represent the DPbl cells.
Extended Data Fig. 3 Delineating the ILC-γ/δ TCR thymocyte cluster and pro-apoptotic cluster from the main α/β TCR lineage pathway.
a. Distinguishing ILC-γ/δ-like cells from DN3b/4 in the DN4 libraries by gene expression. The heatmap on the left shows a manually curated panel of gene transcripts selected by likely high representation in either DN3b/4 or ILC-γ/δ-like cells. Log2 Fold-change (L2FC) and Padj in the DN4 libraries for differential expression between the DN3b/4 clusters and ILC-γ/δ-like clusters are shown in the volcano plot to the right with transcripts associated with ILC development are highlighted in light purple (Id2, Zbtb16, Gata3, Rora). TCR γ and δ transcripts are highlighted in green, and Trbv transcripts highlighted in blue. b. Gene expression profile of the pro-apoptotic cluster. The dominant pro-apoptotic cluster upregulated gene expression changes are similar between all the MHC+ libraries on comparison with the 2 dominant clusters within each of these libraries. All log2-fold changes (L2FC) are relative only to the 3 clusters listed in each heatmap (i.e. local) and not to the average across all clusters in that library.
Extended Data Fig. 4 Development and TCR repertoire analyses for cells growing on MHC+, MHC− and scH-2Kb stromal support cells.
a. Total cell recoveries after 9d development from 2,000 seeded HSC (Representative of 6 experiments examining MHC+ (n = 5), MHC− (n = 6), and scH-2Kb (n = 3)). For all box plots, the box bounds the 1st to 3rd quartiles; where visible, the dotted line within represents mean, and the solid line represents median. Whiskers above and below (maximum and minimum) are defined as (quartile 3 + 1.5 * interquartile range) and (quartile 1 – 1.5 * interquartile range), respectively. P (= 0.0204) determined by two-tailed t test. b. Apparent thymocyte developmental stage representation as fraction of total cells for cultures represented in panel a. c. Stage-specific analysis of β chain clonotype representation/10,000 cells in d9 MHC+, MHC−, and scH-2Kb OP9-DL4 development cultures. Representation of data from replicate experiments of data in Fig. 2c–f. d. TCR β chain clonotype diversity at DN4 on MHC+, MHC−, and scH-2Kb stroma. The total number of TCR β chain clonotypes (black) recovered from 104 cells of each DN4 population isolated after growth for 9d on the varying OP9-DL4 stroma is represented by an ellipse of area in direct proportion to unique clonotype count (5 independent experiments). Percentage shared clonotypes of the total for each condition (MHC+ in blue, MHC− in pink, and scH-2Kb in green) is depicted. Note that the area of overlap only approximates degree of sharing to maintain consistent orientation of the ellipses for presentation. The overlap of MHC+ and scH-2Kb for experiments 4 and 5 is <1% and too small to represent in this format. Statistics and P calculated from two-tailed t test presented on left.
Extended Data Fig. 5 Transcriptome and selected phenotype comparison of MHC+ and MHC− OP9-DL4 cells and select gene expression profiles for the DN4 unusual and DPbl abnormal populations.
a. Comparison of MHC+ and MHC− OP9-DL4 stromal cells for transcriptome and phenotypic differences. 93.6% of transcripts detected shared by MHC+ and MHC− stroma. b. Correlation between cell transcriptomes. Square of two-tailed Pearson correlation coefficient (R2 = 0.958) ideally greater than 0.92 under optimal experimental conditions. c. Differential gene expression is <4% of all transcripts detected. d. Loss of CD1d surface expression in B2m/Tap2 KO MHC− OP9-DL4 and confirmation of lack of MHC Class II expression in MHC+ and MHC− OP9-DL4. e. Raet expression in MHC+ and MHC− OP9-DL4. f. Select transcripts significantly differentially expressed between the MHC− DN3b/4 cluster and the DN4 “unusual” cluster. Heatmap depicts log2-fold change (L2FC) of the DN4 “unusual” cluster relative to the DN3b/4 cluster. Actual L2FC values are listed within the heatmap. g. Co-expression of Cd4 transcript with Cd8a and/or Cd8b1 transcripts in an overlay of the MHC− libraries focussed on the DN4 unusual, DPbl, and DP abnormal clusters. h. Characteristic myeloid gene transcript expression maps to the MHC− DP abnormal cluster. i. Full-length clonotypic TCR β chain transcript expression in 82 of 221 Spi1+ cells (37.1%) in the MHC− DP abnormal cluster. j. Mpo-expressing cells in the DP abnormal cluster and the Mpo+Spi1+ subset co-express T lineage Lck and/or Cd3e. k. DP cell yields after 12 d for DN3a and DN4 cells seeded onto MHC+ or MHC- stromal cells. l. Relative expression by qRT-PCR (normalised to Actb = 1000) of Mpo and Spi1 in DP cells developing from DN3a cells seeded 12 d earlier onto MHC+ or MHC− stromal cells (Cells pooled from 3 separate cultures; n = 7 qRT-PCR replicates; Mpo: P < 0.00001, Spi1: P = 0.000655). m. Relative expression (normalised to Actb = 1000) of Mpo and Spi1 in DP cells developing from DN4 cells seeded 12 d earlier onto MHC+ or MHC− stromal cells (Cells pooled from 3 separate cultures; Mpo: n = 8 qRT-PCR replicates; Spi1: n = 4 qRT-PCR replicates); for l, m: mean ± s.d.; P from two-tailed t-test; representative of 2 independent experiments; Mpo: P = 0.000013, Spi1: P = 0.000233).
Extended Data Fig. 6 Highly proliferating clonotypic progeny cluster together by transcriptional signature.
a. MHC+ DN4 20 most highly represented clonotypes by cell number. b. MHC− DN4 20 most highly represented clonotypes by cell number. The identical MHC+ and MHC− DN4 clonotypic cells to those presented in Fig. 3d and Extended Data Table 3a are shown in their mapped positions in the UMAP projection. Each clonotype is represented for each panel in a unique colour with cell number indicated in key. Note that colours are not directly related to those used in Fig. 3d.
Extended Data Fig. 7 Transcriptome comparison of DN and ISP thymocyte subsets from MHC+ and MHC− mice.
a. Thymocyte subset cell recoveries from thymi of MHC+ and MHC− mice. Mean ± s.d. shown; 3 mice/group; ** p = 0.0169; *** p < 0.0039; **** p < 0.0003 determined by 2-tailed t-test. b. Log2-fold change in expression from global population mean for the MHC− knocked out genes (B2m, H2-Ab1), classical and minor MHCI genes, and MHCII genes. Note that for each thymocyte subset there are 3 replicates except for the MHC− DN4 cells for which there are duplicates. Asterisks highlight transcripts that are upregulated across all MHC− libraries on comparison with MHC+ Q10 (p = 7 × 10−5), H2-T3 (TL) (p = 3 × 10−7), H2-T22 (p = 1 × 10−7) and H2-T-ps (p = 4 × 10−5). P calculated using two-tailed Chi-square test. c. Log2-fold change in expression of all development stage marker genes depicted in Fig. 1a. d. Log2-fold change in TCR Vβ chain segment (Trbv) expression. Mean depicted of triplicates for all libraries except for duplicates for MHC− DN4 samples. e. Log2-fold change in Bcl2a1 family transcripts (upper panel), canonical Bcl2 transcripts (middle panel), and Pim1 protooncogene (lower panel). Mean values presented. f. Log2-fold change in TCR Vα chain segment (Trav) expression. Mean depicted of triplicates for all libraries except for duplicates for MHC− DN4 samples. g. Display of haematopoietic/immune organs from an MHC− dKO mouse with massive thymic growth at 15 months and from age-matched MHC+ control. h. FACS analysis of single cell thymic and splenocyte suspensions stained for CD4 and CD8. Numbers next to gates indicate % of cells in that gate. i. Haematoxylin and eosin staining of representative organs from an age-matched MHC+ wt B6 mouse and an MHC− dKO mouse with leukaemic growth. Thymic cortex indicated by ‘c’, and thymic medulla by ‘m’. Cancellous bone indicated by ‘ca’. Arrow indicates leukaemic cell accumulation adjacent and around a hepatic vein. j. Immunohistochemistry of tumour cells in dKO thymus for TdT (immature thymocytes), CD8 (T lineage) and neutrophil elastase (myeloid lineage) and in dKO spleen metastatic focus for the intracellular domain of Notch 1 (NICD1). i, j: For each tissue and condition, the complete section was examined down to the cellular level and the image presented (~1% of each total section) is representative of that complete section. White bar in all images represents 100 μm.
Supplementary information
Supplementary File 1.
Gene expression level (UMI/cell), log2fold change (global), and Padj for all clusters in all MHC+ libraries – scRNA-seq. MS Excel file: Supplementary-Information-File1.
Supplementary File 2.
Gene expression level (UMI/cell), log2fold change (global), and Padj for all MHC- clusters – scRNA-seq. MS Excel file: Supplementary-Information-File2.xlsx
Supplementary File 3.
TCR β chain clonotypes for DN3, DN4, DPbl and DPsm thymocytes developing on MHC+, MHC-, and scH-2Kb/VSV8 stroma. MS Excel file: Supplementary-Information-File3.
Supplementary File 4.
Representative FACS separation profiles of developing thymocyte-like subsets in vitro and thymocyte subsets in vivo. PDF file: Supplementary-Information-File4.
Supplementary File 5.
Gene expression for DN3a, DN3b, DN4 and ISP cells isolated from MHC+ and MHC- mice. MS Excel file: Supplementary-Information-File5.
Supplementary File 6.
Gene expression analysis of a chromosome Y transcript panel and expression-matched autosomal panel to address aberrant clonal HSC expansion contributing to the MHC- DN4 unusual and DP abnormal populations. MS Excel file: Supplementary-Information-File6.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Duke-Cohan, J.S., Akitsu, A., Mallis, R.J. et al. Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation. Nature 613, 565–574 (2023). https://doi.org/10.1038/s41586-022-05555-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-022-05555-7
This article is cited by
-
Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells
Nature Nanotechnology (2024)
-
Bioengineering translational models of lymphoid tissues
Nature Reviews Bioengineering (2023)
-
The β-selection step shapes T-cell identity
Nature (2023)